Literature DB >> 8238129

Fetal biophysical profile score. VI. Correlation with antepartum umbilical venous fetal pH.

F A Manning1, R Snijders, C R Harman, K Nicolaides, S Menticoglou, I Morrison.   

Abstract

OBJECTIVE: Our objective was to determine the relationship, if any, between the fetal biophysical profile score and antepartum umbilical venous pH. STUDY
DESIGN: This was a prospective observational study conducted concurrently in two centers and involving two discrete high-risk groups of fetuses. Fetal biophysical profile scores were compared with umbilical venous pH values measured in blood obtained by immediate cordocentesis. A total of 493 paired observations of biophysical profile score and pH were made; 104 observations were of fetuses with intrauterine growth retardation and 389 observations were of fetuses with alloimmune anemia.
RESULTS: In both data sets there was a highly significant linear correlation between biophysical profile score and umbilical venous pH. Poor biophysical profile score performance (a score of 0 of 10) was always associated with a pH < 7.20, whereas the pH was always > 7.20 when the biophysical profile score was 10 of 10. Sequenced sensitivity of short-term biophysical variables in the detection of acidemia was observed.
CONCLUSION: The fetal biophysical profile score accurately predicts antepartum umbilical venous pH.

Entities:  

Mesh:

Year:  1993        PMID: 8238129     DOI: 10.1016/0002-9378(93)90002-z

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

Review 2.  Methadone and buprenorphine for the management of opioid dependence in pregnancy.

Authors:  Hendrée E Jones; Loretta P Finnegan; Karol Kaltenbach
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

Review 3.  Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.

Authors:  Christoph C Lees; Roberto Romero; Tamara Stampalija; Andrea Dall'Asta; Greggory A DeVore; Federico Prefumo; Tiziana Frusca; Gerard H A Visser; John C Hobbins; Ahmet A Baschat; Caterina M Bilardo; Henry L Galan; Stuart Campbell; Dev Maulik; Francesc Figueras; Wesley Lee; Julia Unterscheider; Herbert Valensise; Fabricio Da Silva Costa; Laurent J Salomon; Liona C Poon; Enrico Ferrazzi; Giancarlo Mari; Giuseppe Rizzo; John C Kingdom; Torvid Kiserud; Kurt Hecher
Journal:  Am J Obstet Gynecol       Date:  2022-01-10       Impact factor: 10.693

4.  Fetal assessment before and after dosing with buprenorphine or methadone.

Authors:  Amy L Salisbury; Mara G Coyle; Kevin E O'Grady; Sarah H Heil; Peter R Martin; Susan M Stine; Karol Kaltenbach; Manfred Weninger; Hendrée E Jones
Journal:  Addiction       Date:  2012-11       Impact factor: 6.526

5.  Antenatal testing-a reevaluation: executive summary of a Eunice Kennedy Shriver National Institute of Child Health and Human Development workshop.

Authors:  Caroline Signore; Roger K Freeman; Catherine Y Spong
Journal:  Obstet Gynecol       Date:  2009-03       Impact factor: 7.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.